3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Endocrine
1
Breast
1
Conditions
Breast Neoplasms
136
Motor Activity
72
Fatigue
10
Neoplasms
9
Obesity
8
Lymphedema
8
Colorectal Neoplasms
7
Cardiotoxicity
7
Weight Loss
6
Prostatic Neoplasms
5
Breast Cancer Lymphedema
5
Ovarian Neoplasms
3
Breast Cancer Female
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Overweight
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Insulin Resistance
2
Depression
2
Breast Diseases
2
Breast Cancer Survivors
2
Body Weight Changes
2
Atherosclerosis
2
Arthralgia
2
Ventricular Dysfunction, Left
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
palbociclib
2
Ketorolac
2
dapagliflozin
1
Tablets
1
Surgical Procedures, Operative
1
Sulindac
1
Specimen Handling
1
Rivaroxaban
1
Resistance Training
1
Radiotherapy, Conformal
1
Probiotics
1
Pregabalin
1
Plastic Surgery Procedures
1
Omeprazole
1
Neoadjuvant Therapy
1
Methods
1
Mastectomy
1
Massage
1
Losartan
1
Ibuprofen
1
Fish Oils
1
Exercise
1
Cognitive Behavioral Therapy
1
Bevacizumab
1
Art Therapy
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Exercise
×
Breast
×
Clear all
NCT01147367
2016-03-08
ABLE
University of Alabama at Birmingham
Phase NA
Completed
49 enrolled